We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Two New Kits Designed to Promote the Study of RNA-Protein Interactions

By LabMedica International staff writers
Posted on 28 Jun 2010
Two related self-contained kits allow molecular biologists to probe RNA-protein complexes using a modernized version the RNA electrophoretic mobility shift assay (EMSA) technique that replaces radioactive labeling with chemiluminescent detection.

The kits are manufactured by two subdivisions of Thermo Fisher Scientific Inc. (Milford, MA, USA). The first is the LightShift RNA EMSA Kit, which the manufacturer says is the first commercially available EMSA kit. The protocol is based on a biotinylated RNA fragment used to probe protein samples. RNA-protein complexes are then monitored by changes in electrophoretic migration patterns. To detect these changes, a chemiluminescent detection method is used that provides sensitivity comparable to detection of a radioactive label.

Preparing the biotinylated probe in-house is made easy with the second kit, the Thermo Scientific Pierce RNA 3' End Biotinylation Kit. This kit provides the reagents required to produce biotinylated RNA probes for use in chemiluminescent or other detection methods. An enzymatic procedure is used to attach a single biotinylated nucleotide to the 3′ end of an RNA strand that is 22 to 450 nucleotides in length. The reaction can be completed in 30 minutes to two hours.

The biotinylated RNA probes produced in-house cost much less than commercial biotinylated RNA probes. The complete kit contains an unlabeled RNA strand to use as a positive control, a biotinylated-RNA probe standard, RNase inhibitor, glycogen, and ligation-enhancing reagents.

Related Links:
Thermo Fisher Scientific Inc.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
New
Gastrointestinal Panel
Xpert® GI Panel
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.

Latest BioResearch News

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
28 Jun 2010  |   BioResearch

Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework
28 Jun 2010  |   BioResearch

New Autoantibody Target Identified in Neuromyelitis Optica Spectrum Disorder
28 Jun 2010  |   BioResearch